Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 6/20 | 0.46 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.46 |
| ▸ | DHODH | Q02127 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | HTR5A | P47898 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 3/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.42 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12578089 | 0.89 | ESR1 (0.43) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578148 | 0.88 | ESR1 (0.42) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578107 | 0.87 | ESR1 (0.44) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL18201037 | 0.85 | ADORA2A (0.40) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL18935318 | 0.85 | MEN1 (0.47) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578161 | 0.85 | ESR1 (0.43) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL17914708 | 0.84 | ADORA2A (0.43) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578127 | 0.84 | ESR1 (0.42) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578662 | 0.83 | ESR1 (0.41) | ADORA2AADORA1DHODHHTR2BHTR5A | |
| SCHEMBL12578122 | 0.83 | ESR1 (0.41) | ADORA2AADORA1DHODHHTR2BHTR5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106164033-B | The raw material and manufacturing method of cyclometalated iridium complexes | 国立研究开发法人产业技术综合研究所 | 2019-04-19 | — | — | CN | disclosed |
| US-10227366-B2 | Bis-iridium-complexes for manufacturing of ECL-labels | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2019-03-12 | — | — | US | disclosed |
| US-20180362565-A1 | METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2018-12-20 | — | — | US | disclosed |
| CN-108463465-A | Method for producing cyclometalated iridium complex | 国立研究开发法人产业技术综合研究所 | 2018-08-28 | — | — | CN | disclosed |
| US-10053479-B2 | Raw material and production method for cyclometalated iridium complex | TANAKA KIKINZOKU KOGYO K.K. (JP) | 2018-08-21 | — | — | US | disclosed |
| EP-2673284-B1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2017-08-30 | — | — | EP | disclosed |
| EP-2882764-B1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2017-03-01 | — | — | EP | disclosed |
| EP-2882823-B1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2017-02-22 | — | — | EP | disclosed |
| EP-2880042-B1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2017-02-01 | — | — | EP | disclosed |
| CN-106164033-A | The raw material of cyclometalated iridium complexes and manufacture method | 国立研究开发法人产业技术综合研究所 | 2016-11-23 | — | — | CN | disclosed |
| EP-2471800-B1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | NAT INST OF ADVANCED IND SCIEN (JP) | 2014-01-15 | — | — | EP | disclosed |
| US-20120211707-A1 | METAL COMPLEX COMPOSITION AND COMPLEX POLYMER | NATIONAL INST. OF ADV. IND. SCI. AND TECH. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120211707-A1 | METAL COMPLEX COMPOSITION AND COMPLEX POLYMER | NATIONAL INST. OF ADV. IND. SCI. AND TECH. (JP) | 2012-08-23 | — | — | US | disclosed |
| US-20120208999-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-16 | — | — | US | disclosed |
| US-20120208999-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-08-16 | — | — | US | disclosed |
| WO-2012107419-A1 | NEW IRIDIUM-BASED COMPLEXES FOR ECL | ROCHE DIAGNOSTICS GMBH (DE) | 2012-08-16 | — | — | WO | disclosed |
| EP-2471800-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | National Institute of Advanced Industrial Science And Technology (JP) | 2012-07-04 | — | — | EP | disclosed |
| EP-2471889-A1 | METAL COMPLEX COMPOSITION AND COMPLEX POLYMER | Sumitomo Chemical Company, Limited (JP) | 2012-07-04 | — | — | EP | disclosed |
| US-8136974-B2 | Metal coordination compound and light-emitting material containing the same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2012-03-20 | — | — | US | disclosed |
| US-20100317858-A1 | METAL COORDINATION COMPOUND AND LIGHT-EMITTING MATERIAL CONTAINING THE SAME | NATIONAL INSTITUTE OF ADVANCE INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10227366-B2 | Bis-iridium-complexes for manufacturing of ECL-labels | HLCS, PDCD2L, LAS1L | ADORA2A 4684/4885ADORA1 4467/4885DHODH 2767/4885 |
| US-20180362565-A1 | METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX | PRKCA, PRKACG, PRKACB | ADORA2A 280/4885ADORA1 297/4885DHODH 773/4885 |
| US-20100317858-A1 | METAL COORDINATION COMPOUND AND LIGHT-EMITTING MATERIAL CONTAINING THE SAME | CRY1, SOD1, L1CAM | ADORA2A 3736/4885ADORA1 3221/4885DHODH 2568/4885 |
| US-20120208999-A1 | IRIDIUM COMPLEX AND LIGHT EMITTING MATERIAL FORMED FROM SAME | LUC7L2, CRY1, INTS9 | ADORA2A 4336/4885ADORA1 3981/4885DHODH 2160/4885 |
| US-10053479-B2 | Raw material and production method for cyclometalated iridium complex | DTYMK, IPO5, IPMK | ADORA2A 3173/4885ADORA1 2690/4885DHODH 43/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.